Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Atopic“
Suchtreffer
Begriffe & Kennungen
Adtralza · 4.5 · Immune responses to non-live vaccines were assessed in a study in which adult patients with atopic dermatitis
Eintrag öffnenAdtralza · 4.8 · ADA incidences in patients who received tralokinumab for up to 6 years (in phase 2/phase 3 atopic dermatitis s
Eintrag öffnenAdtralza · 4.8 · Conjunctivitis and related events Conjunctivitis occurred more frequently in atopic dermatitis patients who re
Eintrag öffnenAllergie, Soforttyp
Eintrag öffnenCibinqo · 4.8 · A total of 3 850 patients were treated with abrocitinib in clinical studies in atopic dermatitis. Among them 3
Eintrag öffnenCibinqo · 4.8 · Listed in Table 2 are adverse reactions observed in atopic dermatitis clinical studies presented by system org
Eintrag öffnenDermatitis, atopische
Eintrag öffnenDupixent · 4.5 · Immune responses to vaccination were assessed in a study in which patients with atopic dermatitis were treated
Eintrag öffnenDupixent · 4.5 · Immune responses to vaccination were assessed in a study in which patients with atopic dermatitis were treated
Eintrag öffnenDupixent · 4.5 · In a clinical study of atopic dermatitis patients, the effects of dupilumab on the pharmacokinetics (PK) of CY
Eintrag öffnenDupixent · 4.5 · In a clinical study of atopic dermatitis patients, the effects of dupilumab on the pharmacokinetics (PK) of CY
Eintrag öffnenDupixent · 4.8 · 75 Atopic dermatitis
Eintrag öffnenDupixent · 4.8 · Approximately 16 % of adolescent patients with atopic dermatitis who received dupilumab 300 mg or 200 mg Q2W f
Eintrag öffnenDupixent · 4.8 · Approximately 16 % of adolescent patients with atopic dermatitis who received dupilumab 300 mg or 200 mg Q2W f
Eintrag öffnenDupixent · 4.8 · Approximately 5 % of patients with atopic dermatitis, asthma, or CRSwNP who received dupilumab 300 mg Q2W for
Eintrag öffnenDupixent · 4.8 · Approximately 5 % of patients with atopic dermatitis, asthma, or CRSwNP who received dupilumab 300 mg Q2W for
Eintrag öffnenDupixent · 4.8 · Atopic Hand and Foot Dermatitis The safety of dupilumab was assessed in 27 paediatric patients 12 to 17 years
Eintrag öffnenDupixent · 4.8 · Atopic Hand and Foot Dermatitis The safety of dupilumab was assessed in 27 paediatric patients 12 to 17 years
Eintrag öffnenDupixent · 4.8 · Atopic dermatitis
Eintrag öffnenDupixent · 4.8 · Atopic dermatitis The safety profile of dupilumab + TCS (CHRONOS) in adult atopic dermatitis patients) through
Eintrag öffnen